Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Nadavia Pharma ApS
APS
Dissolved
CVR 42878537
Granledet 6
Manufacture of pharmaceutical preparations · NACE 2120
Est. 2021
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2022
DKK -145K
EBITDA margin
100.0%
Equity ratio
-164.8%
Financial strength
Net profit 2022
DKK -117K
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2022
Key figures
Annual report 2022
Revenue
DKK -145K
—
EBITDA
DKK -145K
—
Net profit
DKK -117K
—
Total assets
DKK 47K
—
Equity
DKK -77K
—
Employees
—
—
Company information
Legal name
Nadavia Pharma ApS
CVR number
42878537
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
24. november 2021
Share capital
DKK 40.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Contact
Address
Granledet 6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of pharmaceutical preparations
Companies in Køge
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2022
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2022
Income statement
DKK thousands
Item
2022
Revenue
-145
Staff expenses
-0
EBITDA
-145
Depreciation & amort.
-2
EBIT
-148
Net financials
-1
Profit before tax
-149
Tax
-32
Net profit
-117
Balance sheet
DKK thousands
Item
2022
Total assets
47
Equity
-77
Long-term debt
0
Short-term debt
123
Total debt
123
Financial ratios
5-year trend
EBITDA margin
-14521900.0%
This company
15.8%
Market median
-91910859% vs market
2022
2022
Equity ratio
-164.8%
This company
38.2%
Market median
-531% vs market
2022
2022
Return on equity
-11680000.0%
This company
18.4%
Market median
-63478361% vs market
2022
2022
Net profit margin
-11680000.0%
This company
8.1%
Market median
-144197631% vs market
2022
2022
Asset turnover
-3.12×
This company
1.12×
Market median
-379% vs market
2022
2022
Debt / equity
1.61×
This company
0.62×
Market median
-160% vs market
2022
2022
Annual reports & filings
Annual report 2022
Filed via CVR / Virk · Period 2021-11-24 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (1)
JN
John Nikolaj Hvarre Christensen
Management
Management
2021 – 2024
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Nadavia Holding ApS
Company
100%
100%
2021
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Nadavia Pharma ApS also hold positions in
0
other companies.
Person
Role here
Other companies
John Nikolaj Hvarre Christensen
Management
0 companies